Anemia, Sickle Cell

"Anemia, Sickle Cell" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A disease characterized by chronic hemolytic anemia, episodic painful crises, and pathologic involvement of many organs. It is the clinical expression of homozygosity for hemoglobin S.

Descriptor ID	D000755
MeSH Number(s)	C15.378.071.141.150.150 C15.378.420.155 C16.320.070.150 C16.320.365.155
Concept/Terms	Anemia, Sickle Cell Anemia, Sickle Cell Anemias, Sickle Cell Sickle Cell Anemias Hemoglobin S Disease Disease, Hemoglobin S Hemoglobin S Diseases Sickle Cell Anemia Sickle Cell Disorders Cell Disorder, Sickle Cell Disorders, Sickle Sickle Cell Disorder Sickling Disorder Due to Hemoglobin S HbS Disease Sickle Cell Disease Cell Disease, Sickle Cell Diseases, Sickle Sickle Cell Diseases

Below are MeSH descriptors whose meaning is more general than "Anemia, Sickle Cell".

Diseases [C]
Hemic and Lymphatic Diseases [C15]
Hematologic Diseases [C15.378]
Anemia [C15.378.071]
Anemia, Hemolytic [C15.378.071.141]
Anemia, Hemolytic, Congenital [C15.378.071.141.150]
Anemia, Sickle Cell [C15.378.071.141.150.150]
Hemoglobinopathies [C15.378.420]
Anemia, Sickle Cell [C15.378.420.155]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
Genetic Diseases, Inborn [C16.320]
Anemia, Hemolytic, Congenital [C16.320.070]
Anemia, Sickle Cell [C16.320.070.150]
Hemoglobinopathies [C16.320.365]
Anemia, Sickle Cell [C16.320.365.155]

Below are MeSH descriptors whose meaning is related to "Anemia, Sickle Cell".

Below are MeSH descriptors whose meaning is more specific than "Anemia, Sickle Cell".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anemia, Sickle Cell" by people in this website by year, and whether "Anemia, Sickle Cell" was a major or minor topic of these publications.

Bar chart showing 59 publications over 20 distinct years, with a maximum of 6 publications in 2008

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	3	0	3
1996	2	0	2
1997	2	0	2
2004	1	0	1
2005	1	2	3
2006	2	0	2
2008	5	1	6
2009	2	0	2
2010	2	1	3
2011	1	1	2
2012	5	0	5
2013	5	0	5
2014	3	0	3
2016	1	0	1
2017	2	0	2
2018	4	0	4
2019	1	2	3
2020	3	0	3
2021	4	0	4
2022	3	0	3

Below are the most recent publications written about "Anemia, Sickle Cell" by people in Profiles.

Jean-Baptiste DM, Wassef M, Bolyai SS, Jenerette C. Individuals with Sickle Cell Disease Using SBAR as a Communication Tool: A Pilot Study. Int J Environ Res Public Health. 2022 10 24; 19(21).

View in: PubMed
Reeves SL, Dombkowski KJ, Madden B, Cogan L, Liu S, Kirby PB, Toomey SL. Considerations When Aggregating Data to Measure Performance Across Levels of the Health Care System. Acad Pediatr. 2022 04; 22(3S):S119-S124.

View in: PubMed
Jones KE, Nyman TM, Daly BP, Jacobson LA, Tarazi RA. Executive Functioning Predicts Adaptive Functioning and Self-Care Independence in Pediatric Sickle Cell Disease. J Pediatr Psychol. 2022 02 14; 47(2):206-214.

View in: PubMed
Casella JF, Barton BA, Kanter J, Black LV, Majumdar S, Inati A, Wali Y, Drachtman RA, Abboud MR, Kilinc Y, Fuh BR, Al-Khabori MK, Takemoto CM, Salman E, Sarnaik SA, Shah N, Morris CR, Keates-Baleeiro J, Raj A, Alvarez OA, Hsu LL, Thompson AA, Sisler IY, Pace BS, Noronha SA, Lasky JL, de Julian EC, Godder K, Thornburg CD, Kamberos NL, Nuss R, Marsh AM, Owen WC, Schaefer A, Tebbi CK, Chantrain CF, Cohen DE, Karakas Z, Piccone CM, George A, Fixler JM, Singleton TC, Moulton T, Quinn CT, de Castro Lobo CL, Almomen AM, Goyal-Khemka M, Maes P, Emanuele M, Gorney RT, Padgett CS, Parsley E, Kronsberg SS, Kato GJ, Gladwin MT. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA. 2021 04 20; 325(15):1513-1523.

View in: PubMed
Pittman DD, Hines PC, Beidler D, Rybin D, Frelinger AL, Michelson AD, Liu K, Gao X, White J, Zaidi AU, Charnigo RJ, Callaghan MU. Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers. Blood. 2021 04 15; 137(15):2010-2020.

View in: PubMed
Abu-Hishmeh M, Miranda L, Shakil F, Ahmed T, Epelbaum O. Hammering home the sickle: an instructive case of endobronchial anaplastic large cell lymphoma. Monaldi Arch Chest Dis. 2021 Apr 08; 91(3).

View in: PubMed
Loo S, Brochier A, Wexler MG, Long K, Kavanagh PL, Garg A, Drainoni ML. Addressing unmet basic needs for children with sickle cell disease in the United States: clinic and staff perspectives. BMC Health Serv Res. 2021 Jan 12; 21(1):55.

View in: PubMed
Sahu KK, Siddiqui AD, Cerny J. Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience. Br J Haematol. 2020 07; 190(2):e86-e89.

View in: PubMed
Fantasia HC, Morse BL. Voxelotor for the Treatment of Sickle Cell Disease. Nurs Womens Health. 2020 Jun; 24(3):233-237.

View in: PubMed
Zeng J, Wu Y, Ren C, Bonanno J, Shen AH, Shea D, Gehrke JM, Clement K, Luk K, Yao Q, Kim R, Wolfe SA, Manis JP, Pinello L, Joung JK, Bauer DE. Therapeutic base editing of human hematopoietic stem cells. Nat Med. 2020 04; 26(4):535-541.

View in: PubMed

People

Explore

Similar Concepts

Top Journals